Inflammatory markers in obese adolescents with type 2 diabetes and their relationship to hepatokines and adipokines

Journal of Pediatrics

Volumn 173, Issue , 2016, Pages 131-135

  Reinehr, Thomas ^a   Karges, Beate ^b   Meissner, Thomas ^c   Wiegand, Susanna ^d   Stoffel Wagner, Birgit ^e   Holl, Reinhard W ^f   Woelfle, Joachim ^g  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY HOSPITAL BONN   (Germany)

^f UNIVERSITY OF ULM   (Germany)

^g UNIVERSITY OF BONN   (Germany)

Author keywords

adiponectin; adolescents; fetuin; FGF21; hsCRP; leptin; obesity; TNFalpha; type 2 diabetes mellitus

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; FETUIN A; FIBROBLAST GROWTH FACTOR 21; GAMMA INTERFERON; GLUCOSE; HEMOGLOBIN A1C; HIGH SENSITIVITY C REACTIVE PROTEIN; INSULIN; INTERLEUKIN 1BETA; LEPTIN; METFORMIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AHSG PROTEIN, HUMAN; BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR; TUMOR NECROSIS FACTOR;

ADOLESCENT; ADOLESCENT OBESITY; ADULT; AGE; ARTICLE; B LYMPHOCYTE; BODY MASS; CAUCASIAN; CHILD; CHRONIC INFLAMMATION; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SEX; BLOOD; CASE CONTROL STUDY; OBESITY;

ADIPONECTIN; ADOLESCENT; ALPHA-2-HS-GLYCOPROTEIN; BIOMARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHILD; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; INTERLEUKIN-1BETA; LEPTIN; MALE; OBESITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84961223830     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2016.02.055     Document Type: Article

References (29)

1. M.Y. Donath, and S.E. Shoelson Type 2 diabetes as an inflammatory disease Nat Rev Immunol 11 2011 98 107
2. J.F. Tanti, and J. Jager Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation Curr Opin Pharmacol 9 2009 753 762
3. S. Mirza, M. Hossain, C. Mathews, P. Martinez, P. Pino, J.L. Gay, and et al. Type 2-diabetes is associated with elevated levels of TNF-α-, IL-6, and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study Cytokine 57 2012 136 142
4. J.P. Bastard, M. Maachi, C. Lagathu, M.J. Kim, M. Caron, H. Vidal, and et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance Eur Cytokine Netw 17 2006 4 12
5. A.M. Hennige, H. Staiger, C. Wicke, F. Machicao, A. Fritsche, H.U. Haring, and et al. Fetuin-A induces cytokine expression and suppresses adiponectin production PLoS One 3 2008 e1765
6. A. Koerner, J. Kratzsch, and W. Kiess Adipocytokines: leptin - the classical, resistin-the controversical, adiponectin - the promising, and more to come Best Pract Res Clin Endocrinol Metab 19 2005 525 546
7. M. Bluher Adipokines - removing road blocks to obesity and diabetes therapy Mol Metab 3 2014 230 240
8. J. Diaz-Delfin, E. Hondares, R. Iglesias, M. Giralt, C. Caelles, and F. Villarroya TNF-α represses beta-Klotho expression and impairs FGF-21 action in adipose cells: involvement of JNK1 in the FGF-21 pathway Endocrinology 153 2012 4238 4245
9. R. Lucas, S.J. Parikh, S. Sridhar, D.H. Guo, J. Bhagatwala, Y. Dong, and et al. Cytokine profiling of young overweight and obese female African American adults with prediabetes Cytokine 64 2013 310 315
10. U.A. Ibarra, J. Friberg, D.P. Christensen, C.G. Lund, and N. Billestrup Inflammatory cytokines stimulate bone morphogenetic protein-2 expression and release from pancreatic beta cells J Interferon Cytokine Res 36 2016 20 29
11. T. Reinehr, J. Woelfle, S. Wiegand, B. Karges, T. Meissner, K. Nagl, and et al. Leptin but not adiponectin is related to type 2 diabetes mellitus in obese adolescents Pediatr Diabetes 2015 Apr 16 10.1111/pedi.12276 [Epub ahead of print]
12. T. Reinehr, B. Karges, T. Meissner, S. Wiegand, M. Fritsch, R.W. Holl, and et al. Fibroblast growth factor 21 and fetuin-A in obese adolescents with and without type 2 diabetes J Clin Endocrinol Metab 100 2015 3004 3010
13. T.J. Cole The LMS method for constructing normalized growth standards Eur J Clin Nutr 44 1990 45 60
14. K. Kromeyer-Hauschild, M. Wabitsch, F. Geller, A. Ziegler, H.C. Geiss, V. Hesse, and et al. Percentiles of body mass index in children and adolescents evaluated from different regional German studies Monatsschr Kinderheilkd 149 2001 807 818
15. N. Rajkovic, M. Zamaklar, K. Lalic, A. Jotic, L. Lukic, T. Milicic, and et al. Relationship between obesity, adipocytokines and inflammatory markers in type 2 diabetes: relevance for cardiovascular risk prevention Int J Environ Res Public Health 11 2014 4049 4065
16. Z. Al-Hamodi, M. Al-Habori, A. Al-Meeri, and R. Saif-Ali Association of adipokines, leptin/adiponectin ratio and C-reactive protein with obesity and type 2 diabetes mellitus Diabetol Metab Syndr 6 2014 99
17. S.C. Su, D. Pei, C.H. Hsieh, F.C. Hsiao, C.Z. Wu, and Y.J. Hung Circulating pro-inflammatory cytokines and adiponectin in young men with type 2 diabetes Acta Diabetol 48 2011 113 119
18. K.J. Nadeau, P.S. Zeitler, T.A. Bauer, M.S. Brown, J.L. Dorosz, B. Draznin, and et al. Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity J Clin Endocrinol Metab 94 2009 3687 3695
19. N.A. West, R.F. Hamman, E.J. Mayer-Davis, R.B. D'Agostino Jr., S.M. Marcovina, A.D. Liese, and et al. Cardiovascular risk factors among youth with and without type 2 diabetes: differences and possible mechanisms Diabetes Care 32 2009 175 180
20. N. Gungor, T. Thompson, K. Sutton-Tyrrell, J. Janosky, and S. Arslanian Early signs of cardiovascular disease in youth with obesity and type 2 diabetes Diabetes Care 28 2005 1219 1221
21. A. Sjoholm, and T. Nystrom Inflammation and the etiology of type 2 diabetes Diabetes Metab Res Rev 22 2006 4 10
22. R. Stienstra, C.J. Tack, T.D. Kanneganti, L.A. Joosten, and M.G. Netea The inflammasome puts obesity in the danger zone Cell Metab 15 2012 10 18
23. V.R. Sopasakis, I. Nagaev, and U. Smith Cytokine release from adipose tissue of nonobese individuals Int J Obes (Lond) 29 2005 1144 1147
24. M. Fasshauer, J. Klein, S. Neumann, M. Eszlinger, and R. Paschke Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes Biochem Biophys Res Commun 290 2002 1084 1089
25. S. Nayak, S.Q. Soon, R. Kunjal, R. Ramadoo, O. Baptiste, J. Persad, and et al. Relationship between adiponectin, inflammatory markers and obesity in type 2 diabetic and nondiabetic Trinidadians Arch Physiol Biochem 115 2009 28 33
26. A. Kharitonenkov, J.D. Dunbar, H.A. Bina, S. Bright, J.S. Moyers, C. Zhang, and et al. FGF-21/FGF-21 receptor interaction and activation is determined by betaKlotho J Cell Physiol 215 2008 1 7
27. S.T. Mathews, G.P. Singh, M. Ranalletta, V.J. Cintron, X. Qiang, A.S. Goustin, and et al. Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene Diabetes 51 2002 2450 2458
28. T. Reinehr, J. Woelfle, R. Wunsch, and C.L. Roth Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis J Clin Endocrinol Metab 97 2012 2143 2150
29. R. Coppari, and C. Bjorbaek Leptin revisited: its mechanism of action and potential for treating diabetes Nat Rev Drug Discov 11 2012 692 708